Thus, these data strengthen our suggestion, stressed for other age-related diseases including Alzheimer disease and prostate cancer, that polymorphisms related to TLR4-mediated signaling pathway may have a major influence on the pathophysiology of a disease, such as sporadic TAA, when they operate in combination to create a “risk profile” [56, 57]. Here, TLR4 is linked to Alzheimer disease.